(2S)-2-[[(2S)-5-guanidino-2-[[(2S)-1-[(2S)-5-guanidino-2-[[(2S)-2-methyl-2-[[(2S)-3-(2-naphthyl)-2-[3-(3-pyridyl)propanoylamino]propanoyl]amino]-3-phenyl-propanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide

ID: ALA4759601

Chembl Id: CHEMBL4759601

PubChem CID: 162657581

Max Phase: Preclinical

Molecular Formula: C52H69N15O8

Molecular Weight: 1032.22

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@](Cc1ccccc1)(NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)CCc1cccnc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O

Standard InChI:  InChI=1S/C52H69N15O8/c1-52(30-32-11-3-2-4-12-32,66-46(72)40(62-43(69)22-20-33-13-7-23-59-31-33)28-34-19-21-35-14-5-6-15-36(35)27-34)49(75)65-38(17-9-25-61-51(57)58)48(74)67-26-10-18-41(67)47(73)63-37(16-8-24-60-50(55)56)45(71)64-39(44(54)70)29-42(53)68/h2-7,11-15,19,21,23,27,31,37-41H,8-10,16-18,20,22,24-26,28-30H2,1H3,(H2,53,68)(H2,54,70)(H,62,69)(H,63,73)(H,64,71)(H,65,75)(H,66,72)(H4,55,56,60)(H4,57,58,61)/t37-,38-,39-,40-,41-,52-/m0/s1

Standard InChI Key:  OJAPGLNJFFPLKX-KJOQNZMSSA-N

Alternative Forms

  1. Parent:

    ALA4759601

    ---

Associated Targets(Human)

NMUR1 Tchem Neuromedin-U receptor 1 (374 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NMUR2 Tchem Neuromedin-U receptor 2 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1032.22Molecular Weight (Monoisotopic): 1031.5454AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Takayama K,Mori K,Asari T,Sohma Y,Nomura E,Sasaki Y,Taguchi A,Taniguchi A,Miyazato M,Minamino N,Kangawa K,Hayashi Y.  (2020)  Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.,  30  (18): [PMID:32721452] [10.1016/j.bmcl.2020.127436]

Source